Low Testosterone Study | Central Kentucky Research
AMR performs phase I, II, III, and IV clinical research trials to support pharmaceutical companies in the development of new drugs, devices, and vaccines at 17 locations across the United States. Over 24 years ago, AMR owners began collaborating based on their mutual respect and shared values. Relationships are the foundation of AMR’s success. Our flexible solutions propel clinical trials from ideas to reality through relationships with industry experts you know. To learn more about AMR’s fully integrated network, click here: amrllc.com.


Low Testosterone Study

  • August 16, 2017

The purpose of this study is to evaluate an investigational, oral testosterone replacement therapy for hypogonadal men ages 18 to 65 years old.

Duration:  Approximately 1 year

Number of visits to CKRA:  Up to 14

Compensation:  $75 for each completed clinic visits; $450 for each completed overnight stay

Note:  Qualified participants must be between the ages of 18 and 65 years old, have testosterone levels below 281 ng/dL, and must not suffer from any unstable medical conditions.  Other criteria also apply.